MYH9 and hepatocellular carcinoma: To verify the clinical significance of p-MYH9 (Ser1943), we measured its expression in 171 HCC and normal adjacent tumor tissues by IHC and found that the p-MYH9 (Ser1943) level was significantly upregulated in HCC, which indicates that p-MYH9 (Ser1943) is a potential therapeutic target in HCC (Fig. 6m; Supplementary Fig. 6g).